MedPath

Lidocaine

LIDOCAINE OINTMENT USP, 5%

Approved
Approval ID

a1e2c14f-0682-4b19-9159-de0aca1960c6

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 1, 2010

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code21695-826
Application NumberANDA080198
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 15, 2009
FDA Product Classification

INGREDIENTS (3)

polyethylene glycol 300Inactive
Code: 5655G9Y8AQ
Classification: IACT
polyethylene glycol 1450Inactive
Code: OJ4Z5Z32L4
Classification: IACT
lidocaineActive
Quantity: 50 mg in 1 g
Code: 98PI200987
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine - FDA Drug Approval Details